2021 Q1 Form 10-Q Financial Statement

#000156459021029485 Filed on May 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $165.2K $4.090K
YoY Change 3938.14% -98.1%
Cost Of Revenue $72.78K $72.71K
YoY Change 0.1% -20.48%
Gross Profit $92.38K -$68.62K
YoY Change -234.63% -155.36%
Gross Profit Margin 55.93% -1677.75%
Selling, General & Admin $561.7K $69.52K
YoY Change 707.96% -86.32%
% of Gross Profit 608.04%
Research & Development $728.0K $159.5K
YoY Change 356.55% -67.39%
% of Gross Profit 788.09%
Depreciation & Amortization $12.87K $56.27K
YoY Change -77.12% -15.2%
% of Gross Profit 13.94%
Operating Expenses $1.290M $229.0K
YoY Change 463.24% -77.04%
Operating Profit -$1.210M -$353.9K
YoY Change 242.01% -62.35%
Interest Expense $3.056M $6.486M
YoY Change -52.89% 55.16%
% of Operating Profit
Other Income/Expense, Net $3.057M $6.746M
YoY Change -54.69% 61.37%
Pretax Income $1.846M $6.392M
YoY Change -71.12% 97.24%
Income Tax
% Of Pretax Income
Net Earnings $1.846M $6.392M
YoY Change -71.12% 97.25%
Net Earnings / Revenue 1117.94% 156288.34%
Basic Earnings Per Share $0.51 $0.00
Diluted Earnings Per Share $0.05 $112.10
COMMON SHARES
Basic Shares Outstanding 18.17B 4.759B
Diluted Shares Outstanding 162.6B 57.00B

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.658M
YoY Change
Cash & Equivalents $3.658M
Short-Term Investments
Other Short-Term Assets $108.2K $43.54K
YoY Change 148.44% -76.13%
Inventory $664.8K $510.0K
Prepaid Expenses
Receivables $17.64K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.449M $553.6K
YoY Change 703.7% -42.75%
LONG-TERM ASSETS
Property, Plant & Equipment $16.04K $4.191M
YoY Change -99.62% -3.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $625.0K
YoY Change
Total Long-Term Assets $6.528M $4.992M
YoY Change 30.78% -4.82%
TOTAL ASSETS
Total Short-Term Assets $4.449M $553.6K
Total Long-Term Assets $6.528M $4.992M
Total Assets $10.98M $5.545M
YoY Change 97.95% -10.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $622.7K $1.370M
YoY Change -54.56% -28.48%
Accrued Expenses $2.242M $1.944M
YoY Change 15.32% 13.4%
Deferred Revenue
YoY Change
Short-Term Debt $443.2K $11.79M
YoY Change -96.24% 30.84%
Long-Term Debt Due $6.236M
YoY Change 1657.12%
Total Short-Term Liabilities $3.341M $24.24M
YoY Change -86.22% 23.62%
LONG-TERM LIABILITIES
Long-Term Debt $7.961M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.035M $21.14K
YoY Change 23719.44% -24.07%
Total Long-Term Liabilities $13.00M $21.14K
YoY Change 61377.2% -99.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.341M $24.24M
Total Long-Term Liabilities $13.00M $21.14K
Total Liabilities $16.34M $24.26M
YoY Change -32.66% -1.28%
SHAREHOLDERS EQUITY
Retained Earnings -$419.9M -$417.0M
YoY Change 0.7% 0.41%
Common Stock $1.835M $475.9K
YoY Change 285.48% 1375.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.360M -$18.71M
YoY Change
Total Liabilities & Shareholders Equity $10.98M $5.545M
YoY Change 97.95% -10.72%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $1.846M $6.392M
YoY Change -71.12% 97.25%
Depreciation, Depletion And Amortization $12.87K $56.27K
YoY Change -77.12% -15.2%
Cash From Operating Activities -$2.009M -$249.4K
YoY Change 705.51% -78.53%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $17.65K $254.4K
YoY Change -93.06% -12045.54%
Cash From Investing Activities $17.65K $254.4K
YoY Change -93.06% -12040.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.500M -5.000K
YoY Change -110100.0% -100.42%
NET CHANGE
Cash From Operating Activities -2.009M -249.4K
Cash From Investing Activities 17.65K 254.4K
Cash From Financing Activities 5.500M -5.000K
Net Change In Cash 3.491M 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$2.009M -$249.4K
Capital Expenditures -$20.00K $0.00
Free Cash Flow -$1.989M -$249.4K
YoY Change 697.49% -78.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M4D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M4D
CY2021Q1 asti Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerm
P4Y2M4D
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
477250
CY2021Q1 asti Promissory Note Current
PromissoryNoteCurrent
193200
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3340739
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5021754
CY2020Q4 asti Secured Promissory Notes Net Noncurrent
SecuredPromissoryNotesNetNoncurrent
5405637
CY2021Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7960849
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7813048
CY2021Q1 us-gaap Liabilities
Liabilities
16337022
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
5
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18345583473
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18345583473
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1834558
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
412742098
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-419936401
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5359740
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10977282
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
728036
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
561709
CY2020Q1 asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
333435
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12872
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1375399
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1210241
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
800
CY2021Q1 asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
562079
CY2021Q1 asti Gain Loss On Derivative And Extinguishment Of Debt Net
GainLossOnDerivativeAndExtinguishmentOfDebtNet
3617904
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3056625
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1846384
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18168650140
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162557539029
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2500000
CY2021Q1 asti Stock Issued During Period Value Of Common Stock
StockIssuedDuringPeriodValueOfCommonStock
3000000
CY2021Q1 asti Adjustments To Additional Paid In Capital Relieved On Conversion Of Derivative Liability
AdjustmentsToAdditionalPaidInCapitalRelievedOnConversionOfDerivativeLiability
1686079
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5359740
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-25106781
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6392193
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-18714588
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1846384
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6392193
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12874
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56265
CY2021Q1 asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
158502
CY2020Q1 asti Gain Loss On Disposition And Foreclosure Of Assets
GainLossOnDispositionAndForeclosureOfAssets
-254600
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2692
CY2020Q1 asti Stock Issued During Period Value Issued For Interest Expense Expense Portion
StockIssuedDuringPeriodValueIssuedForInterestExpenseExpensePortion
117514
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
542164
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
771447
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-141
CY2021Q1 asti Warranty Reserve
WarrantyReserve
-463
CY2020Q1 asti Warranty Reserve
WarrantyReserve
-7260
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3617904
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7717150
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12100
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-141
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
130369
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-23860
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
161592
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5365
CY2021Q1 asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
-114339
CY2020Q1 asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
-293125
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-103334
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-140105
CY2021Q1 asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
5413
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3490706
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17648
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
254443
CY2020Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
5000
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5500000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5500000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-312073
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
319921
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2026942
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-249443
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
254600
CY2021Q1 asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
17648
CY2020Q1 asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
-157
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167725
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3658431
CY2021Q1 asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
5800000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5614528
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2026942
CY2021Q1 asti Working Capital
WorkingCapital
1108298
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24867176
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24867176
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24851132
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24848408
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16044
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18768
CY2021Q1 us-gaap Depreciation
Depreciation
2724
CY2020Q1 us-gaap Depreciation
Depreciation
43849
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5475161
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5614528
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
258393
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
720000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
988800
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1018464
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1049018
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1080488
CY2021Q1 asti Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2259194
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7115964
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1501436
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P81M15D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8805
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
594700
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
525626
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14690
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
55410
CY2021Q1 us-gaap Inventory Net
InventoryNet
664800
CY2020Q4 us-gaap Inventory Net
InventoryNet
534431
CY2020Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
5303984
CY2021Q1 asti Extinguishment Of Derivative Liability
ExtinguishmentOfDerivativeLiability
5303984
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 asti Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18345583473
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
97
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
97
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q1 asti Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber
97

Files In Submission

Name View Source Status
0001564590-21-029485-index-headers.html Edgar Link pending
0001564590-21-029485-index.html Edgar Link pending
0001564590-21-029485.txt Edgar Link pending
0001564590-21-029485-xbrl.zip Edgar Link pending
asti-10q_20210331.htm Edgar Link pending
asti-10q_20210331_htm.xml Edgar Link completed
asti-20210331.xsd Edgar Link pending
asti-20210331_cal.xml Edgar Link unprocessable
asti-20210331_def.xml Edgar Link unprocessable
asti-20210331_lab.xml Edgar Link unprocessable
asti-20210331_pre.xml Edgar Link unprocessable
asti-ex311_9.htm Edgar Link pending
asti-ex312_6.htm Edgar Link pending
asti-ex321_7.htm Edgar Link pending
asti-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending